UNSPSC 51143201: Disulfiram

This classification denotes a multidrug resistance modulator and angiogenesis inhibitor with the molecular formula C10H20N2S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TR3MLJ1UAI, chemically known as 1,1-dithiobis(n,n-diethylthioformamide) but generally known as disulfiram, which bears US NIH Compound Identifier 3117. European Medicines Agency schedules Disulfiram in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06326MIG. The term DISULFIRAM is an International Non-Proprietary Name.

UNSPSC 51143201 Disulfiram is a Commodity code that shows minimal recent state and local procurement activity aligned to the nominal scope. The two recent opportunities flagged under this code — Seminole County, Florida's procurement of Naloxone and drug deactivation systems and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs — do not reflect disulfiram acquisition. State and local governments use codes within the broader pharmaceutical and medical supply taxonomy to procure pharmaceuticals, medical devices, and pharmacy administration services, but the specific recent activity under this code does not substantiate disulfiram as a current purchasing priority at the state or local level.

Seminole County's IFB 60459723LAS, posted June 30, 2026, solicits 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health initiatives, with deliveries to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. The Texas HHS Commission's RFI HHS0017013, posted April 3, 2026, pursues vendor capabilities for direct-to-manufacturer pharmacy prescription programs outside traditional pharmacy benefit manager and wholesaler channels. Neither opportunity directly implicates disulfiram procurement, and the code shows no evidence of sustained state or local buying activity for this substance. Firms evaluating this code should verify whether state purchasing offices have reclassified disulfiram-related opportunities under alternative pharmaceutical or medical supply codes, or assess whether direct engagement with state pharmacy benefit programs and health departments will surface relevant future solicitations.